Reumatología

2006

1. Análisis de los pacientes diagnosticados de osteoporosis en un centro de salud urbano. ¿Se conoce la enfermedad por el médico de atención primaria?

   Medicina general, Núm. 81, pp. 843-847

2. Aspectos actuales y perspectivas de futuro del tratamiento de la artritis reumatoide

   Medicine: Programa de Formación Médica Continuada Acreditado, Serie 9, Núm. 69, pp. 4436-4442

3. Clinical research: A primer of practical tips [1]

   Journal of Clinical Rheumatology

4. Consensus document of the Spanish Society of Rheumatology on the use of opioids in the treatment of rheumatic pain

   Reumatologia Clinica, Vol. 2, Núm. SPEC. ISS. 1, pp. 50-54

5. Desarrollo y validación de un cuestionario de satisfacción con el tratamiento en pacientes con artritis reumatoide

   Reumatologia Clinica, Vol. 2, Núm. 3, pp. 137-145

6. Discontinuation rate and factors predictive of the use of hydroxychloroquine in LUMINA, a multiethnic US cohort (LUMINA XL) [3]

   Lupus

7. EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT)

   Annals of the Rheumatic Diseases, Vol. 65, Núm. 10, pp. 1301-1311

8. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

   Annals of the Rheumatic Diseases, Vol. 65, Núm. 10, pp. 1312-1324

9. Efecto de la edad y de la menopausia sobre la masa ósea

   Revista Española de Enfermedades Metabólicas Oseas, Vol. 15, Núm. 4, pp. 57-62

10. Efficacy of tacrolimus (FK-506) in the treatment of recalcitrant juvenile dermatomyositis: Study of 6 cases

    Medicina Clinica, Vol. 127, Núm. 18, pp. 697-701

11. Hemophagocytosis during fludarabine-based SCT for systemic juvenile idiopathic arthritis [1]

    Bone Marrow Transplantation

12. Switching TNF antagonists in patients with chronic arthritis: An observational study of 488 patients over a four-year period

    Arthritis Research and Therapy, Vol. 8, Núm. 1

13. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XXXI: Factors associated with patients being lost to follow-up

    Lupus, Vol. 15, Núm. 1, pp. 19-25

14. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: Results of a nested matched case-control study

    Annals of the Rheumatic Diseases, Vol. 65, Núm. 6, pp. 785-790

15. Systemic lupus erythematosus in a multiethnic US cohort: Clinical features, course, and outcome in patients with late-onset disease

    Arthritis and Rheumatism, Vol. 54, Núm. 5, pp. 1580-1587

16. Systemic lupus erythematosus in a multiethnic US cohort: XXXIV. Deficient mannose-binding lectin exon 1 polymorphisms are associated with cerebrovascular but not with other arterial thrombotic events

    Arthritis and Rheumatism, Vol. 54, Núm. 6, pp. 1940-1945

17. Systemic lupus erythematosus in a multiethnic cohort (LUMINAXXXIX): Relationship between hormone replacement therapy and disease activity over time [2]

    Lupus

18. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time

    Annals of the Rheumatic Diseases, Vol. 65, Núm. 9, pp. 1168-1174

19. Using serum urate levels to determine the period free of gouty symptoms after withdrawal of long-term urate-lowering therapy: A prospective study

    Arthritis Care and Research, Vol. 55, Núm. 5, pp. 786-790

20. Validez de la escalera analgésica de la OMS en reumatología

    Seminarios de la Fundación Española de Reumatología, Vol. 7, Núm. 3, pp. 121-127